Go look at the short interest in mnkd and the recent price, 68 million shares ALL under water by no less than 3.00, but think what u want.
If shares are in a margin account and you have a zero margin balance I believe they cannot short your shares, if you have a balance they can short your shares. It has long been held that if you put in a sell order it locks up your shares. If there are shares available they do not need to call your shares until a sale happens. So it is my understanding that putting a sell order in does not lock them up. That said, calling ones broker to find out their rules is a good thing, and requesting your shares not be lent out should be honored. A cash only account shares cannot be touched. I have no margin, never will again.
Last winter 18 MONTHS ago ? It is normal for these negotiations to take up to a year, the announcement was March 10, 2014, four months ago. If they get pricing anytime this year 2014, that is fast. Granted enrollment has been SLOWER than I had hoped but LP feels 312 patients before 2014 ends, adding patients is an issue that could be a wrench. What you shorts think is the technology does not work, um, that is the big mistake in the thesis. TELL YOU what, in the phase 1-2 dcvax L study even if each subject was cherry picked, the results were still stellar and due to the treatment. Cherry picked gbm patients by and large still have only a year at best two survival times. DCvax L, has over 50% of this group beating the odds, that is not luck, or coincidence.
Prostate studies, ovarian studies etc., too many positives for it to be chance random luck. To make a claim like direct is worthless is fool hearty wishful thinking. Study the science behind dendritic cells and at some point you will ask why they heck are so many companies using a man made chemical. D cells as you read this have marked and killed several cancer cells in your body. They target them day in day out from birth. When they fail at their job you get sick. As basic as this sounds it is what happens.
The NWBO technology takes a MASSIVE amount of D cells in numbers not seen in nature, and it jump starts the cancer killing process. So likely to work you should have been able to figure it out, but then they did give the Nobel price to the guy who did, so maybe not.
Yes you can see small amounts of shorts covering ie., as they cover those shares reenter the available to short float. IAB went from zero to 50K since 9:30, opk likely churns slowly higher with this number bouncing between zero and 300K. VERY little ammo available to keep the top nailed down. By Monday Tues we might get a rush of short covering and no shares to cover with, we will see. Figure three days in the 9's people will look at margin exposure if the broker doesn't do it for them, plus 13.75% margin and the stock is up 7-8% in the past three sessions. 21% loss so far.
I have had major issues here also, so I do believe all passwords have been compromised.
Similar situation existed last Sept/Oct when Opk ran from 8.35 to 12.95 on no real news in just over 2 weeks. Even LW was forced to buy shares in a long account to mitigate his short. Of course he saved his GROSSLY under performing FUNDS butt with his well timed hit piece. No only was he in trouble but the other 38M on the wrong side at the time. He had an out sized position. Likely long gone.
Hate to say it but one point AF made is VALID. Here is why. After X years, with 16k-18K gbm patients in the US alone we have yet to reach full enrollment, 312 patients. Study design p = .02, SO to raise p = .05 maybe 50 more patients needed, LINDA gave no number, a GUESS. SO how long to enroll 50 more if by end of year we are at 312??? Likely 1 full YEAR, then waiting for PFS adds roughly 8-9 months, as patients trickle in. Top line data could be 2017, not 2015. With approval by 2018 if no stop for efficacy.
Yes we might get phase 1/2 on direct, but we have had similar phase 1/2 prostate with great numbers and are still in the 5-6 range.
German pricing is likely less than 5 months out, but then with the anemic patient enrollment here who knows what the uptake will be.
So though AF is ANAZZ he is making a VALID point about the phase 3 timeline, unfortunately, all his junk is not complete trash, occasionally he hits on a valid point by trowing tons of mud at the wall.
I knew increasing size was a real possibility, and the timeline hit, but chose to ignore it. Linda P has mentioned it three times now, so I am taking off my blinders to this likely event. We might have to all rethink this timeline because looking like 2015 might be out.
There are as of this minute 400K shares available to short at interactive brokers, a week ago that number hit a low that I saw of 30K, so some covering took place in the past 6-7 days.
No idea on current number, all anyone knows is it is not 312, and enrollment has been way slower than hoped for. I think to get to 312 the timeline has moved from early 2014, to late 2014, so if they have to add 50 more patients to increase P, I am guessing, year to enroll 50 more, plus 1 year for pfs, 2017, not worried but not happy about it. There will be other news but phase 3 could take much longer if we expand. What I do not get is WHY the enrollment is taking FOREVER, given early data one would think they would be OVER enrolled given this much time/with 50 SITES !!!!
This study has gone on for quite a long time as is. According to MD Anderson there are roughly 12-14K new US cases each year taken from article dated March 2011, Glioblastoma cure remains elusive. So in the past three years there have been about 45K new cases, and NWBO has yet to enroll 312 patients??? Or roughly .006 of the population. The one problem I do have is that NWBO has not given the number of patients, blind, double blind, regardless, this fact should be available. Increasing N by even 50, GIVEN the painfully slow enrollment could increase top line data by 2 years??? Figure no less than a year to enroll given current inability to hit 312 at this point, then time to PFS data no less than 8 months, get a recliner, this data will not be out until 2017.
I am long, but am realizing my time horizon might be moved out by 2 years, minimum, from 2015 to 2017. The good news is direct data will be finalized by 2015, and Germany negotiations should be done in another 3-4 months if not sooner. AF is anaz, but his point on expanding trial size has some merit, it really pushes the time line out a couple years, not months as I first thought. If we do not anticipate 312 until q4, given 8 months as a reference to pfs, we are still looking at early 2016.
Yes that is working, but why does that work? I am under the impression too that if I Log in to post using the incognito window, this same issue will reappear. Strange is that it is two browsers and I just reloaded a new google browser.
It basically has me blocked from opening links and posting without a ton of effort, right click, new tab, etc., not worth the effort. Not sure if it is my computer, ISP, or at yahoo. I tried two browsers google and IE, cleaned up computer, etc., still has issues.
I have had to right click and open in new tab to read posts. Yahoo is garbage. Has worked on rare occasions since yesterday.
No telling if they are selling at prices this low. The ATM is an overhang but it is better than a big dilution in one shot. The last two quarters were 22 million worth of shares at 6.34, followed by only 5 million worth because they elected to stop selling shares because of share price. You R right though, the atm is an issue, but each Q funds have gobbled up most of the dilution, but not all. Arry is a mid 2015-early 2016 story, we are early.
Only 2,000 now. Means little covering going on, the more that cover the more reenter the availability. It also means if any buying kicks in, shorts have no/little ammo. Keep shares in a cash only account, cannot be lent out.
Cramer is not allowed to have any positions in any stocks other than his charitable trust. The street Cramer and Stephanie have their own opinions that do not always align with the News letter writers like AF at thestreetdot..m The news letter downgraded a stock I own twice from buy to hold to sell, yet Cramer on MAD has not wavered with his buy buy buy when callers call in. Though he is the CEO he is not involved with the everyday functions or ramblings of the news letter, though he puts his charitable portfolio in it.
As far as AF, and his holdings, I have no clue, and could care less.
This 9.00 target is the highest, Jefferies and Nicholous both have 8.00, bmo 4.00, zachs, 5.40, piper Jaffray 7.00. consensus pt = 6.88 according to analyst rating network.